“à•”ƒŠƒ“ƒNƒŠƒXƒg
ƒA
ƒC
ƒE
ƒG
ƒI
ƒJ
ƒL
ƒN
ƒP
ƒR
ƒT
ƒV
ƒX
ƒZ
ƒ\
ƒ^
ƒ`
ƒc
ƒe
ƒg
ƒi
ƒj
ƒk
ƒl
ƒm
ƒn
ƒq
ƒt
ƒw
ƒz
ƒ}
ƒ~
ƒ€
ƒ
ƒ‚
ƒ„
Ġ
ƒˆ
ƒ‰
ƒŠ
ƒ‹
ƒŒ
ƒ
ƒ
ƒ’
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
ŠÖ˜A—pŒêW
yƒAz
ƒAƒXƒpƒ‰ƒMƒi[ƒ[ ¨
L-ƒAƒXƒpƒ‰ƒMƒi[ƒ[
ƒAƒlƒLƒVƒLƒ“A2
ƒ¿è÷—±
ƒ¿
2
-ƒAƒ“ƒ`ƒvƒ‰ƒXƒ~ƒ“
ƒ¿
2
-ƒvƒ‰ƒXƒ~ƒ“ƒCƒ“ƒqƒrƒ^[ ¨
ƒ¿
2
-ƒAƒ“ƒ`ƒvƒ‰ƒXƒ~ƒ“
ƒAƒƒXƒeƒŠƒbƒNŒø‰Ê
ƒAƒ“ƒ`ƒgƒƒ“ƒrƒ“
yƒCz
ˆêŽŸü—n
ƒCƒ“ƒeƒOƒŠƒ“ƒ¿IIb/ƒÀ3 ¨
GPIIb/IIIa
yƒEz
ƒEƒjóÔŒŒ‹…
ƒEƒƒLƒi[ƒ[
ƒEƒƒLƒi[ƒ[Œ^ƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒŠƒx[ƒ^
yƒGz
ƒGƒ|ƒLƒVƒhŒ^ƒrƒ^ƒ~ƒ“K
ƒGƒ€ƒfƒ“-ƒ}ƒCƒ„[ƒzƒtŒo˜H
yƒIz
d‚Ý•t‚«Šô‰½•½‹Ï
d‚Ý•t‚«ŽZp•½‹Ï ¨
‰Ád•½‹Ï
d‚Ý•t‚«’²˜a•½‹Ï
yƒJz
‰ð“œŒn ¨
ƒGƒ€ƒfƒ“-ƒ}ƒCƒ„[ƒzƒtŒo˜H
‰Ád•½‹Ï
Šˆ«‰»•”•ªƒgƒƒ“ƒ{ƒvƒ‰ƒXƒ`ƒ“ŽžŠÔ(APTT)
ƒJƒ{ƒbƒgŠÂ
Š™óÔŒŒ‹…
ƒJƒ‹ƒWƒIƒŠƒsƒ“
ƒÁ-ƒJƒ‹ƒ{ƒLƒVƒOƒ‹ƒ^ƒ~ƒ“Ž_ŽcŠî
ŠÒŒ³Œ^ƒrƒ^ƒ~ƒ“K
ŠÔÚƒN[ƒ€ƒXŽŽŒ± ¨ ŠÔÚRƒOƒƒuƒŠƒ“ŽŽŒ±
Š®‘SRŒ´
Š®‘SR‘Ì
Š¦—â‹ÃW‘f
yƒLz
Šô‰½•½‹Ï
‹…óÔŒŒ‹…
ƒLƒ…ƒrƒŠƒ“-ƒAƒ€ƒjƒIƒ“ƒŒƒX•¡‡‘Ì
‹ÃŒÅ‘æIˆöŽq ¨
ƒtƒBƒuƒŠƒmƒQƒ“
‹ÃŒÅ‘æXIIIˆöŽq
yƒNz
ƒN[ƒ€ƒXŽŽŒ±
¨
’¼ÚƒN[ƒ€ƒXŽŽŒ±
¨
’¼ÚRƒOƒƒuƒŠƒ“ŽŽŒ±
¨ŠÔÚƒN[ƒ€ƒXŽŽŒ± ¨ ŠÔÚRƒOƒƒuƒŠƒ“ŽŽŒ±
ƒNƒ}ƒŠƒ“
ƒOƒ‹ƒR[ƒX-6-ƒŠƒ“Ž_ƒfƒqƒhƒƒQƒi[ƒ[(G6PD)
yƒPz
ŒŒ¬”ƒ¿è÷—±
ŒŒ¬”‹ÃW”\ŒŸ¸
ŒŒ¬””Zõè÷—±
yƒRz
D‰–Šî«”Á“_
RƒOƒƒuƒŠƒ“ŽŽŒ±
Œð·¬‡ŽŽŒ±¨
•â³ŽŽŒ±
i—AŒŒ‚̌𷎎Œ±‚Ƃ͈قȂéj
Œð·ŽŽŒ±
Œã’n‘ÑŒ»Û ¨
ƒvƒƒ][ƒ“Œ»Û
ŒÜ”—v–ñ
ƒR[ƒ“–@
yƒTz
Ž_‰»Œ^ƒrƒ^ƒ~ƒ“K
ŽZp•½‹Ï
yƒVz
ƒWƒNƒ}ƒ[ƒ‹
ƒWƒtƒHƒXƒtƒ@ƒ`ƒWƒ‹ƒOƒŠƒZƒ[ƒ‹ ¨
ƒJƒ‹ƒWƒIƒŠƒsƒ“
2,3-ƒWƒzƒXƒzƒOƒŠƒZƒŒ[ƒg (G6PD)
¨
BohrŒø‰Ê
¨
ƒyƒ“ƒg[ƒXƒŠƒ“Ž_Œo˜H
Žl•ªˆÊ”
Žl•ªˆÊ”͈Í
is«ƒgƒƒ“ƒrƒ“‘jŠQ”\
yƒXz
ƒX[ƒp[ƒƒ‹ƒtƒ@ƒŠƒ“
ƒXƒC[ƒgƒNƒ[ƒo[’†“Å
yƒZz
¶•¨Šw“I‹U—z«”½‰ž
¶•¨—R—ˆ»•i
ƒZƒ‹ƒsƒ“
‘O’n‘ÑŒ»Û ¨
ƒvƒƒ][ƒ“Œ»Û
ü—n§Œä•s”\ó‘Ô ¨
ƒ¿
2
-ƒAƒ“ƒ`ƒvƒ‰ƒXƒ~ƒ“
, ¨
ü—n”½‰ž
ü—n”½‰ž
yƒ\z
‘Š‰Á•½‹Ï ¨
ŽZp•½‹Ï
‘Šæ•½‹Ï ¨
Šô‰½•½‹Ï
‘gDˆöŽq
‘gDƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒ`ƒx[ƒ^
yƒ^z
‘ȉ~ÔŒŒ‹…
yƒ`z
’n‘ÑŒ»Û ¨
ƒvƒƒ][ƒ“Œ»Û
’†‰›’l
’²˜a•½‹Ï
’¼ÚƒN[ƒ€ƒXŽŽŒ± ¨
RƒOƒƒuƒŠƒ“ŽŽŒ±
yƒcz
yƒez
“S‘ãŽÓ
ƒeƒ…[ƒL[‚Ì” ƒqƒQ}
yƒgz
“Á’趕¨—R—ˆ»•i
yƒiz
yƒjz
“ñŽŸü—n
“ñ–{½‘gDƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒ`ƒx[ƒ^
yƒkz
yƒlz
yƒmz
”Zõè÷—±
yƒnz
ƒnƒCƒ“ƒc¬‘Ì
” ƒqƒQ}
”jÓÔŒŒ‹…
ƒpƒbƒyƒ“ƒnƒCƒ}[¬‘Ì
ƒnƒvƒeƒ“
yƒqz
ƒrƒ^ƒ~ƒ“B12
ƒrƒ^ƒ~ƒ“K
ƒrƒ^ƒ~ƒ“KƒGƒ|ƒLƒVƒhŠÒŒ³y‘f
ƒrƒ^ƒ~ƒ“KˆË‘¶«’`”’Ž¿
ƒrƒ^ƒ~ƒ“KƒTƒCƒNƒ‹
•W“IÔŒŒ‹…
ƒsƒ‹ƒx[ƒgƒLƒi[ƒ[
yƒtz
ƒtƒBƒuƒŠƒmƒQƒ“
ƒtƒBƒuƒŠƒmƒQƒ“•ª‰ð
ƒtƒBƒuƒŠƒ“•ª‰ð
ƒtƒBƒƒLƒmƒ“ ¨
ƒrƒ^ƒ~ƒ“K
1
ƒtƒFƒƒ|[ƒ`ƒ“
¨
“S‘ãŽÓ
ƒtƒHƒ“ƒrƒ‹ƒuƒ‰ƒ“ƒhˆöŽq
•sŠ®‘SR‘Ì
•sŠ®‘SR‘Ì
ƒtƒbƒNŒ»Û ¨
ƒvƒƒ][ƒ“Œ»Û
•”•ªRŒ´
ƒvƒ‰ƒXƒ~ƒmƒQƒ“
ƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒ`ƒx[ƒ^
ƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒ`ƒx[ƒ^ƒCƒ“ƒqƒrƒ^[
ƒvƒ‰ƒXƒ~ƒ“
ƒtƒŠƒbƒvŒ»Û
ƒtƒŠƒbƒvEƒtƒƒbƒvŒ»Û
ƒvƒƒEƒƒLƒi[ƒ[
ƒvƒƒ][ƒ“Œ»Û
ƒvƒƒgƒƒ“ƒrƒ“
ƒvƒƒgƒƒ“ƒrƒ“ŽžŠÔ(PT)
•ªˆÊ”
y‚Öz
•½‹Ï
@¨
‰Ád•½‹Ï
@¨
Šô‰½•½‹Ï
@¨
‘Š‰Á•½‹Ï
@¨
ŽZp•½‹Ï
@¨
‘Šæ•½‹Ï
@¨
’²˜a•½‹Ï
ƒxƒCƒY„’è
ƒwƒpƒŠƒ“ƒRƒtƒ@ƒNƒ^Šˆ«
ƒwƒvƒVƒWƒ“ ¨
“S‘ãŽÓ
ƒwƒ‚ƒOƒƒrƒ“
ƒyƒ“ƒg[ƒXƒŠƒ“Ž_Œo˜H
yƒzz
ƒ{[ƒAŒø‰Ê
•êW’c‰ðÍ
ƒ|ƒXƒgƒ][ƒ“Œ»Û ¨
ƒvƒƒ][ƒ“Œ»Û
ƒzƒXƒtƒ@ƒ`ƒWƒ‹ƒGƒ^ƒm[ƒ‹ƒAƒ~ƒ“
ƒzƒXƒtƒ@ƒ`ƒWƒ‹ƒRƒŠƒ“
•â³ŽŽŒ±
yƒ}z
yƒ~z
ƒ~ƒNƒVƒ“ƒOƒeƒXƒg¨
•â³ŽŽŒ±
yƒ€z
yƒz
ƒƒiƒLƒmƒ“ ¨
ƒrƒ^ƒ~ƒ“K
2
yƒ‚z
yƒ„z
yĠz
—LŠjÔŒŒ‹…
—Lž™ÔŒŒ‹…
—LŒûÔŒŒ‹…
yƒˆz
—tŽ_
yƒ‰z
ƒ‰ƒCƒIƒ“Œ»Û
ƒ‰ƒCƒIƒjƒ[[ƒVƒ‡ƒ“
yƒŠz
ƒŠƒWƒ“Œ‹‡•”ˆÊ
ƒŠƒXƒgƒZƒ`ƒ“‹ÃW
yƒ‹z
—Ü“HÔŒŒ‹…
yƒŒz
yƒz
ƒƒXƒi[ƒCƒ“ƒfƒbƒNƒX(Rosner's index)
yƒz
ƒƒ‹ƒtƒ@ƒŠƒ“
yAz
acanthocyte ¨ —Lž™ÔŒŒ‹…
ADAMTS13
annexin A2
antithrombin
APTT
ƒ¿-antithrombin
ƒ¿
2
-AP ¨
ƒ¿
2
-antiplasmim
ƒ¿IIb/ƒÀ3 ¨
GPIIb/IIIa
ƒ¿
2
-PI ¨
ƒ¿
2
-plasmin inhibitor
yBz
ƒÀ-antithrombin
BFP ¨
¶•¨Šw“I‹U—z«”½‰ž
BohrŒø‰Ê
box plot ¨
” ƒqƒQ}
box-and-whisker plot¨
” ƒqƒQ}
2,3-BPG ¨ 2,3-Bisphospoglycerate ¨
2,3-DPG
yCz
CabotŠÂ
carboxypeptidase B ¨
TAFI
cardiolipin
cleaved antithrombin
codocyte ¨ •W“IÔŒŒ‹…
cristae
cross mixing test ¨
•â³ŽŽŒ±
coumarin
cross-reactive material
yDz
dacryocyte ¨ —Ü“HÔŒŒ‹…
dicumarol
Donath-LandsteinerR‘Ì
2,3-DPG
drepanocyte ¨ Š™óÔŒŒ‹…
yEz
echinocyte ¨ ƒEƒjóÔŒŒ‹…
elliptocyte ¨ ‘ȉ~ÔŒŒ‹…
Embden-MeyerhofŒo˜H
yFz
five number summary
flip-flopŒ»Û ¨
ŒŒ¬”–ŒƒŠƒ“Ž‰Ž¿
yGz
G6PD ¨
BohrŒø‰Ê
, ¨
ƒyƒ“ƒg[ƒXƒŠƒ“Ž_Œo˜H
GlaŽcŠî ¨
ƒÁ-ƒJƒ‹ƒ{ƒLƒVƒOƒ‹ƒ^ƒ~ƒ“Ž_ŽcŠî
Glycoprotein Ia/IIa•¡‡‘Ì
Glycoprotein Ib/XI/V•¡‡‘Ì
Glycoprotein IIb/IIIa
Glycoprotein VI
GPIa/IIa•¡‡‘Ì
GPIb/XI/V•¡‡‘Ì
GPIIb/IIIa
GPVI
yHz
hapten
Heinz body
Howell-Jolly¬‘Ì
yIz
ICA (index of circulating anticoagulant)¨
Rosner's index
INR; International Normalized Ratio ¨
PT-INR
IQR ¨
Žl•ªˆÊ”͈Í
ISI; International Sensitivity Index
ITP
yJz
yKz
yLz
L-asoaraginase
latent antithrombin
LBS
yMz
menaquinone ¨
ƒrƒ^ƒ~ƒ“K
2
Met-ƒ¿
2
-antiplasmin
mixing test ¨
•â³ŽŽŒ±
Moschcowitz‚Ì5’¥Œó ¨
ŒŒð«ŒŒ¬”ÂŒ¸«Ž‡”Á•ay—Õ°Çóz
yNz
Non-plasmin binding-ƒ¿
2
-antiplasmin
NPB-ƒ¿
2
-antiplasmin
; non-plasmin binding-ƒ¿
2
-antiplasmin
yOz
yPz
Pappenheimer¬‘Ì
PAI-1 ¨ plasminogen activator inhibitor-1
PAI-2 ¨ plasminogen activator inhibitor-2
PB-ƒ¿
2
-antiplasmin ¨
plasmin/plasminogen binding-ƒ¿
2
-antiplasmin
PC ¨ (1)
protein C
, (2)
phosphatidylcholine
, (3) personal computer
pentose phosphate pathway
PIVKA
PIVKA-II
plasmin
plasmin/plasminogen binding-ƒ¿
2
-antiplasmin
Plasminogen
plasminogen activator
plasminogen activator inhibitor-1
prelatent antithrombin
protein C
protein S
prothrombin
prothrombin time
PS ¨ (1)
protein S
, (2)
Phosphatidilserine
PT ¨
prothrombin time
PT-INR ¨
prothrombin time-international normalized ratio
yQz
quartile
yRz
Ristcetin‹ÃW
Rosner's index
ySz
schizocyte ¨ ”jÓÔŒŒ‹…
single chain t-PA
spherocyte ¨ ‹…óÔŒŒ‹…
stomatocyte ¨ —LŒûÔŒŒ‹…
sct-PA ¨
single chain t-PA
scuPA ¨
uPA
superwarfarin
yTz
TAFI ¨ thrombin activatable fibrinolysis inhibitor
tissue factor
tct-PA
tcuPA
teardrop cell ¨ —Ü“HÔŒŒ‹…
Tukey's box prot
two chain t-PA ¨
tct-PA
two chain uPA ¨
tcuPA
yUz
uPA
urokinase ¨
uPA
yVz
vitamin B12
vitamin K
vitamin K cycle
von WillebrandˆöŽq
yWz
warfarin
yXz
yYz
yZz